US Federal Court assures safety from Ranitidine, dismisses 2,500 lawsuits alleging cancer linkage with drug
The court ruling comes as a big win for pharmaceutical companies like Pfizer, Sanofi, GSK and Boehringer Ingelheim.;
Advertisement
Washington: A United States Federal court dismissed the cancer linkage associated with Zantac (Ranitidine) assuring the safety of the use of Ranitidine for Indian patients.
Almost 2,500 lawsuits alleging links between heartburn medication Zantac (Ranitidine) and cancer were dismissed by the court in US district of Florida.
According to the judge, almost 2,500 lawsuits filed by plaintiffs in the federal court were based on flawed science and the only reliable testing of the blockbuster drug showed an 'unprovable risk of cancer'.
The US district court's decision to slap down the cancer litigations over Zantac (Ranitidine), assured that science prevails over propaganda.
Ranitidine which came into existence over four decades ago has been on the WHO list of essential medicines for several years now. There is enough real-world evidence data on the product's efficacy and safety. The medicine has since long been consumed by patients all over the world.
Read also: Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.